Please Wait.....
Report
Chemotherapy At Home Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps), By Route of Administration (Oral v/s Intravenous), By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others), By Company, and By Region
Market Report I 2022-12-01 I 112 Pages I TechSci Research
The global chemotherapy at home services market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing incidences of different types of cancer, and rising preferences towards at-home medical care, are bolstering the growth of the market. Chemotherapy is a medical practice that is mainly conducted for cancer patients. It uses powerful chemicals to kill fast growing cells in human body. The other factors supporting the market's growth are growing need to reduce the period of inpatient stays, the increasing population, changing societal behavior, increasing government investments, growth in geriatric population, and technological advancements in field of chemotherapy devices. Also, strategic partnerships and collaborations are fueling the growth of the market. For instance, CVS Health and the Cancer Treatments Centers of America (CTCA) worked in partnership to bolster the access to chemotherapy at home for eligible patients.
Increasing Incidence of Cancer and Rise in Geriatric Population
Rise in occurrences of various types of cancer such as lung cancer, cervical cancer, breast cancer, and others, are propelling the growth of the market. Cancer is considered as second largest cause of mortality and disability across the globe. According to National Cancer Institute, roughly 5.5 million people in the United States are affected by cancer. This number is projected to rise to 20.3 million by 2026. Owing to the rapid increase in number of patients suffering from cancer, the surge in demand for chemotherapy rises, which augments the growth of chemotherapy at home services market, globally. Furthermore, rising geriatric population is also a key factor contributing the growth of the market. For instance, according to the U.S. Census Bureau, approximately 77.0 million people will be aged 65 & above by 2034, and this number is anticipated to reach 94.7 million by 2060.
Increasing Preference for At-Home Medical Care and Various Technological Advancements
Rising consumer inclination toward at-home medical care is bolstering the market growth, globally. The limited movement capabilities by elderly population are fueling the growth of the market. Rising incidences of hospital infections, and cost effectiveness of these devices are curbing the market growth. For instance, in 2021, as per the study, titled 'Predicting Patients at Risk for Prolonged Hospital Stays', only 1.2% of hospital stays lasted more than 21 days. Moreover, various initiatives are taken by government and non-government organization to bolster the growth of the market. In 2021, VS Health and the Cancer Treatments Centers of America (CTCA) collaborated to augment the access to chemotherapy at home for qualified patients.
Market Segmentation
The global chemotherapy at home services market is segmented into product, route of administration, cancer type, and company. Based on product, the market is divided into chemotherapy drugs and chemotherapy infusion pumps. Based on route of administration, the market is segmented into oral and intravenous. Based on cancer type, the market is segmented into breast cancer, blood cancer, ovarian cancer, colorectal cancer, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising prevalence of different type of cancer and rising geriatric population base in the country.
Market Players
Portea Medical Pvt. Ltd., HealthCare atHOME, Ubiqare Health Pvt. Ltd., Vitalis Health and Home Care Pty Ltd, Medibank Private Limited, Advocate Medical Group, View Health Pty Ltd, and CVS Health Corporation are some of the leading companies operating in the market.
Report Scope:
In this report, global chemotherapy at home services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Chemotherapy At Home Services Market, By Product:
o Chemotherapy Drugs
o Chemotherapy Infusion Pumps
- Chemotherapy At Home Services Market, By Route of Administration:
o Oral
o Intravenous
- Chemotherapy At Home Services Market, By Cancer Type:
o Breast Cancer
o Blood Cancer
o Ovarian Cancer
o Colorectal Cancer
o Others
- Chemotherapy At Home Services Market, By Region:
o North America
- United States
- Canada
- Mexico
o Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
o Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Chemotherapy At Home Services Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Service Overview
2. Research Methodology
3. Impact of COVID-19 on Global Chemotherapy At Home Services Market
4. Executive Summary
5. Voice of Customer
5.1. Cancer Prevalence, By Gender
5.2. Cancer Prevalence, By Age Group
5.3. Cancer Prevalence, By Region
5.4. Factors Contributing Switch To Chemotherapy At Home
5.5. Barriers To Adoption of Chemotherapy At Home Services
6. Global Chemotherapy At Home Services Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Chemotherapy Drugs v/s Chemotherapy Infusion Pumps)
6.2.2. By Route of Administration (Oral v/s Intravenous)
6.2.3. By Cancer Type (Breast Cancer, Blood Cancer, Ovarian Cancer, Colorectal Cancer, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America Chemotherapy At Home Services Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Route of Administration
7.2.3. By Cancer Type
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Chemotherapy At Home Services Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Cancer Type
7.3.2. Mexico Chemotherapy At Home Services Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Cancer Type
7.3.3. Canada Chemotherapy At Home Services Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Cancer Type
8. Europe Chemotherapy At Home Services Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Route of Administration
8.2.3. By Cancer Type
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Chemotherapy At Home Services Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Cancer Type
8.3.2. Germany Chemotherapy At Home Services Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Cancer Type
8.3.3. United Kingdom Chemotherapy At Home Services Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Cancer Type
8.3.4. Italy Chemotherapy At Home Services Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Cancer Type
8.3.5. Spain Chemotherapy At Home Services Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Cancer Type
9. Asia-Pacific Chemotherapy At Home Services Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Route of Administration
9.2.3. By Cancer Type
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Chemotherapy At Home Services Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Cancer Type
9.3.2. India Chemotherapy At Home Services Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Cancer Type
9.3.3. Japan Chemotherapy At Home Services Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Cancer Type
9.3.4. South Korea Chemotherapy At Home Services Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Product
9.3.4.2.2. By Route of Administration
9.3.4.2.3. By Cancer Type
9.3.5. Australia Chemotherapy At Home Services Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Product
9.3.5.2.2. By Route of Administration
9.3.5.2.3. By Cancer Type
10. South America Chemotherapy At Home Services Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Route of Administration
10.2.3. By Cancer Type
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Chemotherapy At Home Services Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Cancer Type
10.3.2. Argentina Chemotherapy At Home Services Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Cancer Type
10.3.3. Colombia Chemotherapy At Home Services Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Route of Administration
10.3.3.2.3. By Cancer Type
11. Middle East and Africa Chemotherapy At Home Services Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Product
11.2.2. By Route of Administration
11.2.3. By Cancer Type
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Chemotherapy At Home Services Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Product
11.3.1.2.2. By Route of Administration
11.3.1.2.3. By Cancer Type
11.3.2. Saudi Arabia Chemotherapy At Home Services Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Product
11.3.2.2.2. By Route of Administration
11.3.2.2.3. By Cancer Type
11.3.3. UAE Chemotherapy At Home Services Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Product
11.3.3.2.2. By Route of Administration
11.3.3.2.3. By Cancer Type
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Portea Medical Pvt. Ltd.
14.2. HealthCare atHOME
14.3. Ubiqare Health Pvt. Ltd.
14.4. Vitalis Health and Home Care Pty Ltd
14.5. Medibank Private Limited.
14.6. Advocate Medical Group
14.7. View Health Pty Ltd
14.8. CVS Health Corporation
15. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security